and biomedical discovery
The excellent research work carried out by IDIS results in the obtaining of technological results capable of generating intellectual and industrial property rights, including patents.
IDIS makes these intellectual and industrial property assets available to all stakeholders belonging to the biomedical sector. Our collaboration with companies interested in our technology portfolio can result in:
- Agreement for the development of technology (TRL increase) with option to a subsequent operating licence.
- A intellectual or industrial property licence agreement for its commercial use.
P201730798 / PCT/EP2018/065725. In vitro method for detecting tumor growth and diagnosing or pronosticating the risk of metastasis in human subject that has been diagnosed with uveal melanoma
EP17382100 / PCT/EP2018/054979. Method for prognosis of the outcome of patients with heart failure (HF) by identifying patients at high risk of re-entry or death after hospitalization for “de novo” heart failure.
Leptin immunosuppression for obesity treatment
EP18382204.8. Anti-leptin Affinity Reagents For Use In The Treatment Of Obesity And Other Leptin-resistance Associated Diseases.
EP18382513. Nanostructure lipid system. Specialized administration system for the lysosomal release of enzymes used in the enzymatic replacement treatment of lysosomal storage diseases.
EP19382094. Development of a new treatment for heterotopic ossification (OH) based on a drug repositioning for use in the prevention or treatment of abnormal bone growth
Pharmaceutical composition comprising corticoids and a repurposed drug to use it in the prevention/treatment of sepsis and/or toll like receptor 4 (TLR4) -mediated inflammatory processes.
Odontopack: package of solutions for Dentistry
P201830122. Standardizing device for clinical photography and research.
P201830256. Simulator for teaching intraoral surgical techniques.
P201830057. Oral surgical retractor with protective attachment for particle projection techniques.